The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in platinum-resistant ovarian cancer.
 
Agustin A. Garcia
No Relationships to Disclose
 
John L. Hays
Consulting or Advisory Role - Eisai
 
Gregory Michael Cote
Consulting or Advisory Role - Advance Medical Designs
Research Funding - Agios (Inst); Boston Biomedical (Inst); Epizyme (Inst); Macrogenics (Inst); PharmaMar (Inst)
 
Carlos Becerra
Consulting or Advisory Role - Novocure
Speakers' Bureau - Celgene; Lilly; Taiho Pharmaceutical
 
Adrian Langleben
No Relationships to Disclose
 
Susie K Lau
No Relationships to Disclose
 
Lynda D. Roman
No Relationships to Disclose
 
Colleen Catherine McCormick
No Relationships to Disclose
 
Donald A. Richards
Consulting or Advisory Role - Boehringer Ingelheim; Insys Therapeutics; IntegraGen; Lilly; Pharmacyclics
Speakers' Bureau - Celgene
 
Fadi S. Braiteh
Employment - US Oncology
Honoraria - Ambry Genetics; Amgen; BIND Biosciences; bioTheranostics; Caris Life Sciences; Incyte; Insys Therapeutics; Ipsen; Lilly; Merrimack; MolecularHealth; Novartis; Novocure; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Ambry Genetics; Amgen; BIND Biosciences; Biotheranostics; Caris Life Sciences; Foundation MEdicine; INcyte
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Genomic Health; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merrimack; Pfizer; Sanofi
Travel, Accommodations, Expenses - Ambry Genetics; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Foundation Medicine; Genomic Health; HERON; Incyte; Insys Therapeutics; Ipsen; Lilly; Merrimack; MolecularHealth; Novartis; Pfizer; Roche/Genentech; Sanofi
 
Habte Aragaw Yimer
No Relationships to Disclose
 
Stephen Lane Richey
Employment - Texas Oncology
Consulting or Advisory Role - Prometheus; Sanofi
Research Funding - US Oncology
 
William Jeffery Edenfield
No Relationships to Disclose
 
Kimiko Kossler
Employment - Boston Biomedical
 
Stephanie Hume
Employment - Boston Biomedical
 
Youzhi Li
Employment - Boston Biomedical
 
Matthew Hitron
Employment - Boston Biomedical
 
Chiang Li
Employment - Boston Biomedical